BDNF promotes the axonal regrowth after sciatic nerve crush through intrinsic neuronal capability upregulation and distal portion protection  by Zheng, Jinyu et al.
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BDNF  enhances  the  outcomes  of functional  recovery  after  sciatic  nerve  crush  injury.
BDNF  triggers  multiple  effects  to promote  axon  regrowth.
The  activation  of  neuronal  intrinsic  regeneration  is  increased.
The  distal  portion  atrophy  is delayed.
 r  t i  c  l  e  i  n  f  o
rticle history:
eceived 11 June 2015
eceived in revised form 17 March 2016
ccepted 4 April 2016
vailable online 4 April 2016
eywords:
DNF
a  b  s  t  r  a  c  t
Nowadays  peripheral  nerve  injurie  occurs  more  common,  the  outcome  is  often  poor  because  of  the  inef-
fective  treatment.  Recent  researches  revealed  the  duration  of BDNF  administration  acts  a  positive  role
during  the  nerve  regeneration,  but  its  potential  mechanisms  beneath  the  behavioral  recovery  and  axonal
regrowth  after  peripheral  nerve  injury  are  still  controversial.  To  observe  the  potential  mechanisms  we
established  sciatic  nerve  injury  model  and  detected  the  expression  of  several  axonal  regeneration  and
function  related  genes.  The  results  showed  that,  BDNF  promotes  axonal  regrowth  through  increasing  the
activation  of  neuronal  intrinsic  growth  capacity  and strengthening  the  deference  effects  against  distalCI
oe spreading
AMP
ap43
EM
portion  atrophy.  To  further  study,  we  determined  the  expression  of protein  associated  to  neuronal  intrin-
sic growth  capacity  and  investigated  the  ultrastructure  of  the  distal  portion  of  the  injured  nerve  were
analyzed.  These  data  revealed  that BDNF  triggers  multiple  effects  including  neuronal  intrinsic  growth
capacity  improvement  and  distal  portion  atrophy  protection  to  promote  behavioral  recovery  following
 in m
rs.  Pusciatic  nerve  crush  injury
© 2016  The  Autho
. IntroductionToday, injury to the nerve of peripheral nervous system (PNS)
ccurs commonly and lacks of effective treatment, which results
n long-term disabling and reducing the quality of life to clini-
Abbreviations: BDNF, brain derived neurotrophic factor; cAMP, cyclic adeno-
ine monophosphate; CNS, central nervous system; CREB, cAMP-response element
inding protein; Gap-43, growth associated protein 43; GAPDH, glyceraldehyde-3-
hosphate dehydrogenase; GDNF, glial cell line-derived neurotrophic factor; PNS,
eripheral nervous system; qRT-PCR, quantitative real time polymerase chain reac-
ion; TEM, transmission electron microscopy; STAT3, signal transducer and activator
f  transcription 3.
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cal patients. According to the previous studies, the prevalence of
peripheral nerve injury arises to about 3% among trauma patients
[12] which needed surgical repair. Despite decades of signiﬁcant
advances in human nerve repair, the patients would often still
facing suboptimal function recovery after clinical surgery [15].
The main issues we need to address are how to promote axonal
regeneration while prevent the chronic denervation changes of
distal portion [1]. In the recent studies, researchers found that
brain-derived neurotrophic factor (BDNF) has play some positive
roles during the nerve regeneration in the central nervous system,
including promoting the molecules (such as cAMP, Gap-43 and c-
jun) expression which contributes to regulating intrinsic axonal
regeneration [9,10,5,7]. Additionally, BDNF may  also be involved in
providing nutritional supports for the distal portion [4,16,8]. In this
research we hypothesized that BDNF could increase the behavioral
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unction through promoting intrinsic axonal regeneration capabil-
ty and protecting distal portion from denervation. So we designed
nd performed the experiments as follow.
. Experimental procedures
.1. Animals
Adult male C57BL/6J mice (180 in total) weighing 20–22 g were
sed in this research. All animals were maintained in a temperature
nd humidity controlled environment, and allowed for standard
ouse chow and water ad lib, with a 12:12 h light: dark cycle.
.2. Surgery
All experimental procedures were approved by the Admin-
stration Committee of Experimental Animals, Nanjing Medical
niversity. All surgical experiments were performed by inhalation
nesthetic (2% isoﬂuorane in 98% oxygen) on adult male mice (8–12
eeks old). After that, the sciatic nerve was squeezed with smooth
orceps for 60 s. After injury, the wound was sutured and the mice
ere allowed to recover on heated pad. In the sham-operated con-
rols, the sciatic nerve was only exposed but without crush injury.
.3. Experimental design
We  separated all animals into four groups in this research (n = 10
er group): (1) sham-operated controls; (2) model group which
ciatic nerve was performed crash injury; (3) BDNF administra-
ion (200 pg/L in sterile distilled water; Life Technologies, Grand
sland, NY, USA) group which mice were treated with BDNF after
rash injury; (4) anti-BDNF treatment (1.5 g/L  in sterile distilled
ater; Chemicon, Temecula, CA, USA) group which mice received
nti-BDNF treatment after crush injury. All drugs were intramuscu-
ar injected in plantar muscle on left hindlinb of mouse once daily
t a volume of 0.1 mL.
.4. Toe spreading test
To assess motor recovery after nerve injury (sciatic nerve crush
njury), the movement of the each toe was evaluated. We  performed
he analysis as described before [2]; Fig. 1A). Full spreading was
eﬁned as a complete, wide, and sustained (at least 2 s) spreading
f each toe. Mice were scored when a full response was observed
n the contralateral side to the injury. Mice were evaluated twice
n each experimental session with at least a 45-minute interval.
coring was done by whom blinded to the group design.
.5. qRT-PCR
Dissociated L4 and L5 spinal cord were prepared from experi-
ental adult male mice at day 14 after the surgical procedure. For
issue preparation, mice were anesthetized by chloral hydrate (7%),
hen an incision was made at the back and the spinal cord was  care-
ully exposed. Removed L4 and L5 of the spinal cord then minced
ith eye scissors on ice. Total mRNA of tissues was isolated by using
RIzol Reagent (Invitrogen, Grand Island, NY, USA) then reverse-
ranscribed by using the PrimeScriptTM RT reagent Kit (TaKaRa,
apan). RT-qPCR was performed with the corresponding primers
Table 1) and the SYBR® Premix Ex TaqTM II (Takara, Japan) by using
tepOnePlusTM System (Applied Biosystems). Gene expression was
ormalized by 18s and data was analyzed with StepOne Software
nd fold changes determined with GraphPad Prism 5 Software.Letters 621 (2016) 1–8
2.6. LANCETM cAMP assay
As mentioned before, L4 and L5 the spinal cord were removed
then minced with eye scissors on ice. The samples were then lysed
with lysis buffer on ice for 10 min. After that, spun at 14000 rpm
(16000 g) for 10 min  at 4 ◦C. Finally collected the supernatant and
assessed the cAMP concentration according to LANCETM cAMP 384
Kit (PerkinElmer Life and Analytical Sciences, Inc. USA) instruction.
2.7. Western blotting assay
As described before, dissociated L4 and L5 spinal cord were
prepared from experimental adult male mice at day 14 after the sur-
gical performance. Protein samples from spinal cord were extracted
using RIPA buffer (Beyotime, Nanjing, JS, China) supplemented
with a protease inhibitor cocktail (Roche, Indianapolis, IN, USA).
After protein concentration determination, equal amounts of pro-
tein was loaded in each lane, resolved on 10% SDS poly-acrylamide
gradient gels, and transferred onto a 0.45-m NC membrane (Mili-
pore, Billerica, MA,  USA). Then membrane was blocked with 5%
BSA and incubated with anti-Gap-43 (1:1000; Milipore), anti-p-
STAT3 (1:1000; Abcam), anti-STAT3 (1:1000; Abcam), anti-p-cjun
(1:1000; Abcam), anti-cjun (1:1000; Abcam), anti-CREB (1:1000;
Abcam) and anti-GAPDH (1:1000; Sigma) overnight at 4◦ C, washed,
and incubated with HRP-conjugated anti-rabbit or anti-mouse sec-
ondary antibodies. Immunoreactive bands were visualized by the
Immobilon Western Chemiluminescent HRP Substrate (Milipore).
Quantiﬁcation of band intensity was  performed by Quantity One
software (Bio-Rad, Hercules, CA, USA). The intensity of the Gap-
43 band was normalized to GAPDH. Experiments were repeated in
triplicate.
2.8. Transmission electron microscopy (TEM)
We  dissociated the sciatic nerve from adult male mice at 5 weeks
after sciatic nerve crush injury. Samples of the sciatic nerve were
prepared as previously described [13]. All specimens were exam-
ined with Hitachi H-7000 electron microscope and images were
acquired through a SIA-8CCD camera mounted on the microscope
for examination with Northern Eclipse Software (Cheektowaga, NY,
USA). The reduction in myelin thickness was  conﬁrmed by calcu-
lating the G-ratio of the individual myelinated ﬁbers (at least 100
per group), which was  calculated as axon diameter/ﬁber diameter.
2.9. Statistical analysis
All data were presented as the mean ± SEM, differences between
groups were compared by using a one-way analysis of variance
(ANOVA), with post-hoc Student LSD (least signiﬁcant difference)
pairwise comparisons applied as appropriate. For all behavioral test
analysis, 2-way repeated measures ANOVA, with post-hoc Bon-
ferroni analysis between groups where appropriate was  utilized.
Signiﬁcant differences were considered for p < 0.05. Statistical cal-
culations were carried out with GraphPad Prism 5 Software.
3. Results
3.1. BDNF promotes motor functional recovery after sciatic nerve
injury in mouse
To investigate the role of BDNF during peripheral nerve repair
after injury, we initially established sciatic nerve injury model in
C57BL/6J mouse and recorded the recovery process as described
before [2]; Fig. 1A). The data showed that the sciatic nerve crush
injury induces a severe damage to the motor function of mice
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Fig. 1. BDNF promotes the motor functional recovery after sciatic nerve injury in mouse by toe spreading test after sciatic nerve crush injury. (A) Representative pictures of
mice  at various stages of recovery after sciatic nerve crush. Score 0—no spreading, 1—intermediate spreading with all toes, 2—full spreading. (B) Motor recovery, assessed by
toe  spreading test. BDNF administration group mice had a faster appearance of the initial (C) and full (D) of the sensory response in comparison to model group after sciatic
nerve  crush. (n = 9–10 per group, data are presented as mean ± SEM; ###p < 0.001 compared with sham, *p < 0.05 compared with model; one-way ANOVA followed by Turkey
test).
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Fig. 2. The mRNA expression tested by qPCR after sciatic nerve crush injury in mouse. BDNF increases the mRNA expression of Mpz  (A), Mbp  (B), cjun (C) and STAT3 (D), but
without changing the mRNA expression of BDNF (E) and GDNF (F). (n = 3 per group, data are presented as mean ± SEM; #p < 0.05, ##p < 0.01 compared with sham; *p < 0.05,
**p  < 0.01, ***p < 0.001 compared with model; one-way ANOVA).
Table 1
The primers used in RT-qPCR.
Gene Forward PCR primer Reverse PCR primer Product length
STAT3 CAATACCATTGACCTGCCGAT GAGCGACTCAAACTGCCCT 109
Jun  CCTTCTACGACGATGCCCTC GGTTCAAGGTCATGCTCTGTTT 102
BDNF  TCATACTTCGGTTGCATGAAGG AGACCTCTCGAACCTGCCC 137
(
r
c
t
(
aGDNF  TATGGGATGTCGTGGCTGTC 
Mbp  AATCGGCTCACAAGGGATTCA 
Mpz  CGGACAGGGAAATCTATGGTGC 
Fig. 1B). At the meanwhile, BDNF administration accelerated the
ecovery process while anti-BDNF treatment delayed. For further
onﬁrmation of the functional recovery promotion, we  analyzed
he time needed for initial response and the time of full response
Fig. 1C and D). After the sciatic nerve crush injury, the mice showed
 time of initial and full response at about 12 and 24 days after theCAGGCATATTGGCGGCGG 78
TCCTCCCAGCTTAAAGATTTTGG 74
TGGTAGCGCCAGGTAAAAGAG 106
injury. These two  parameters in mice with BDNF treatment were
remarkably reduced to about 7 and 18 days. In contrast, anti-BDNF
administration signiﬁcantly delayed these processes to nearly 17
and 30 days.
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Fig. 3. BDNF up-regulates intrinsic growth capacity in mouse after sciatic nerve crush injury. (A) The LANCE cAMP assay in L4-L5 of the spinal cord after sciatic nerve crush
injury. (B) The regulation of pathways related to intrinsic growth capacity in spinal cord L4-L5 at 2 weeks after sciatic nerve crush injury. (C) The quantiﬁcation of band
intensity (n = 3 per group, data are presented as mean ± SEM; #p < 0.05, ##p < 0.01, ###p < 0.001 compared with sham; *p < 0.05, **p < 0.01, ***p < 0.001 compared with model;
one-way ANOVA).
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Fig. 4. BDNF protects the distal portion of the nerve and muscles. (A)Transmission electron microscope (TEM) analysis was performed on the proximal nerve lesions at
3 total a
p ean ±
A
3
r
f
i5  days after sciatic nerve crush injury. (B) Detection of the myelinated axons (% of 
erformed as axon diameter/ﬁber diameter. (n = 3 per group, data are presented as m
NOVA).
.2. BDNF regulates the mRNA expression associated with axonal
egenerationAs previously research revealed [1], there has two important
eatures of axonal regeneration. One is the activation of neuronal
ntrinsic growth capacity and the other is the degeneration in thexons). (C) The distribution of myelin thickness. (D) The G-ratio analysis which was
 SEM; ###p < 0.001 compared with sham; *p < 0.05 compared with model; one-way
distal portion. To reveal the potential mechanisms, we quantiﬁed
the mRNA expression which is associated to the intrinsic growth
capacity, trophic support and distal portion hypotrophy (Fig. 2).
Our results showed that BDNF increases the levels of Mpz, Mbp,
cjun and STAT3 (Fig. 2A-D) directly indicating the degree of distal
portion hypotrophy and the activation of neuronal intrinsic growth
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apacity in peripheral axonal regeneration, but without changing
he BDNF and GDNF mRNA expression (Fig. 2E and F) which impli-
ated in trophic support. So we next focused on evaluating the
ntrinsic growth capacity and distal portion degeneration.
.3. BDNF up-regulates intrinsic growth capacity in mouse after
ciatic nerve crush injury
How do peripheral axon lesions increase the activation of intrin-
ic growth capacity? Researchers had revealed that intracellular
AMP level is a critical molecule that upregulated after periph-
ral nerve injury, and cAMP analog injection is sufﬁcient to initiate
nd promote neuronal regrowth [11,9]. And the action of cAMP
roceeded through blocking PKA, upregulating cjun pathway and
ncreasing Gap-43 expression to promote axonal elongation. Fur-
hermore, these transcriptional effects seemed to be regulated by
REB and STAT3 activation [3,6]. To assess the regulation of BDNF
n intrinsic growth capacity, we chose these critical factors for eval-
ation. From the data, it indicated that BDNF signiﬁcantly increases
he cAMP expression level (Fig. 3A) and upregulates the cjun path-
ay through elevating the CREB and STAT3 activation (Fig. 3B).
.4. BDNF postpones the de-generation in the distal portion
The function of myelin in CNS is to promote the speed of conduc-
ion, increase conduction ﬁdelity and reduce energy consumption,
owever, the biological structure of myelin is complex and vulner-
ble to injury. It is widely recognized that the g-ratio calculated as
xon diameter/ﬁber diameter is highly reliable for assessing axonal
yelination. To evaluate the degree of denervation at the distal
ortion from injury site, we used transmission electron microscopy
TEM) to detect the cross sections of sciatic nerve segments (∼3 mm
istal to lesion) at day 35 after sciatic nerve crush injury. Those
esults showed deﬁcits in myelinated ﬁber population in model
roup compared to sham group (Fig. 4A and B). An increase of
yelinated ﬁbers was noted in BDNF administration mice, but anti-
DNF administration displayed a signiﬁcant deterioration situation
Fig. 4A and B). From the composite histogram, it suggested that
he myelin thickness statistics was also correlated to the result of
he number of myelinated ﬁbers (Fig. 4C). In order to present the
ata more impressive, we performed the G-ratio analysis. Accord-
ng to the previously study, the optimized value of G-ratio ranged
.55–0.68 [14]. And in this study, the mean G-ratio of BDNF group
as 0.7 ± 0.086 which was much greater than that obtained from
odel and anti-BDNF group (Fig. 4D).
. Discussion
Compared to central nervous system (CNS) which usually can-
ot regenerate, injury occurred in peripheral nerves system (PNS)
ften initiates spontaneously regeneration, owing to the activation
f intrinsic regrowth capacity of neurons and permissive environ-
ent [5]. However, despite the signiﬁcant advances achieved over
he past century, functional recovery after peripheral nerve injury
s often poor and results in long-term disabling among patients. Our
esults suggested that BDNF remarkably promotes the outcomes of
unctional recovery in mice after sciatic nerve crush injury. More-
ver, BDNF not only notably accelerated the presence of the initial
esponse, and also accelerated the full recovery in different test
acility. These collectively evidence indicated that BDNF adminis-
ration is a potential approach to treat peripheral nerve injury.
For a successful nerve regeneration, it should include processes
s follow: ﬁrst, the cell body of an injured neuron must receive
ccurate and timely information about the site and extent of axonal
amage in order to increase its intrinsic growth capacity and suc-
essfully regenerate. Second, the balance between inhibitory cuesLetters 621 (2016) 1–8 7
present in the environment and the intrinsic growth capacity of
the injured neurons determines the proper extent of axonal regen-
eration following injury. Finally with the assistant of clues in the
microenvironment, axons regrow through the lesion and reconnect
with the target organ to repair the function. Here, to reveal the
potential mechanisms, we chose several typical proteins related
to the intrinsic axon growth ability (STAT3, cjun), trophic sup-
port (BDNF, GDNF) and myelin function (Mpz, Mbp) for analysis.
The results displayed that BDNF could signiﬁcantly upregulate the
mRNA of STAT3, cjun, Mpz  and Mbp  expression, but not mRNA of
BDNF and GDNF. These clues suggested that BDNF may  acceler-
ate the functional recovery through improving the intrinsic axon
growth ability and myelin function.
So we  next evaluated the intrinsic growth capacity and the
degree of denervation at the distal portion. The data showed BDNF
signiﬁcantly increase the cAMP level during the regeneration pro-
cess. And the CREB-cjun-STAT3-Gap-43 pathway which associated
with the intrinsic axonal growth capacity was also upregulated.
Thus, BDNF could increase and maintain the intrinsic growth capac-
ity to a high level. At the meanwhile, BDNF also delayed the atrophy
of distal portion, and these effects eventually contribute to accel-
erating functional recovery.
There is compelling evidence indicating that combination use of
multiple neurotrophic factors have been shown to promote periph-
eral regeneration better than monotherapy [18,17], but the exact
role of each neurotrophic factor acts during the repair process is
not clear. For the further application, we need to investigate the
role of each neurotrophic factor and the optimal proportion. In this
study, we reported that BDNF promotes neuronal intrinsic growth
capacity and delays portion atrophy, but its role in reducing portion
atrophy is not so excited compared to its role on promoting neu-
ronal intrinsic growth capacity, suggesting that BDNF combined
with a medicine which could inhibit the distal atrophy more sig-
niﬁcantly will come into play.
5. Conclusion
Collectively, our data showed that BDNF administration result
in signiﬁcantly promoting functional recovery in mice after sci-
atic nerve injury, and the potential mechanisms are mainly via the
neuronal intrinsic growth capacity improvement and distal portion
atrophy protection.
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